mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-06 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |